Our results suggest that HBO may enhance PPARα expression in skeletal muscle in a pattern similar to PPARα agonists, which is likely part of its mechanism of action in protecting against HFD induced fatty acid metabolism dysfunction and obesity. The gene discussed is PPARA; the disease is Obesity.